Integrative Analysis of Immunological Data to Explore Chronic Immune T-Cell Activation in Successfully Treated HIV

Marie-Quitterie Picat1,2,3,4,5, Isabelle Pellegrin6, Juliette Bitard6

  • 1Centre INSERM U1219 Bordeaux Population Health, Bordeaux, France.

Plos One
|January 4, 2017
PubMed

Insights

Cytomegalovirus (CMV) directly impacts chronic immune activation (CIA) in treated HIV patients. Autoimmunity indirectly affects CIA through alpha-interferon, warranting further study in HIV management.

Area of Science:

  • Immunology
  • Virology
  • Infectious Diseases

Background:

  • Chronic immune activation (CIA) persists in successfully treated HIV-infected patients.
  • Understanding the interplay between viral infections, autoimmunity, and immune activation is crucial for managing long-term HIV complications.

Purpose of the Study:

  • To investigate the relationships between cytomegalovirus (CMV)-induced responses, autoimmune-induced responses, microbial translocation, and CIA in treated HIV patients.
  • To explore the mediating role of alpha-interferon (IFN-α) in these complex interactions.

Main Methods:

  • A cross-sectional study within the ANRS CO3 Aquitaine Cohort of HIV-1-infected patients on sustained antiretroviral therapy.
  • Structural equation modeling (SEM) was used to analyze data, including CMV responses (Quantiferon, ELISPOT), autoimmune markers, and IFN-α-stimulated genes.
  • Chronic immune activation (CIA) was defined by HLA-DR+/CD38+ expression on CD8+ T-cells.

Main Results:

  • CMV-induced response directly impacted CIA (βstd = 0.56, p=0.0004).
  • Autoimmune response indirectly influenced CIA via the alpha-interferon pathway (autoimmunity to IFN-α: βstd = 0.36, p=0.0401; IFN-α to CIA: βstd = 0.39, p=0.0044).
  • Microbial translocation was not associated with CIA. The IFN-α latent variable significantly affected CIA across analyses.

Conclusions:

  • The direct effect of CMV on CIA and the involvement of alpha-interferon in CIA are confirmed.
  • The indirect role of autoimmunity in CIA through the alpha-interferon pathway requires further investigation.
  • These findings highlight potential therapeutic targets for managing chronic immune activation in HIV-infected individuals.
Abstract